157 related articles for article (PubMed ID: 25699138)
1. Melanocortin antagonist tetrapeptides with minimal agonist activity at the mouse melanocortin-3 receptor.
Doering SR; Todorovic A; Haskell-Luevano C
ACS Med Chem Lett; 2015 Feb; 6(2):123-7. PubMed ID: 25699138
[TBL] [Abstract][Full Text] [Related]
2. Structure-activity relationships of the melanocortin tetrapeptide Ac-His-DPhe-Arg-Trp-NH(2) at the mouse melanocortin receptors: part 2 modifications at the Phe position.
Holder JR; Bauzo RM; Xiang Z; Haskell-Luevano C
J Med Chem; 2002 Jul; 45(14):3073-81. PubMed ID: 12086493
[TBL] [Abstract][Full Text] [Related]
3. Structure-activity relationships of the unique and potent agouti-related protein (AGRP)-melanocortin chimeric Tyr-c[beta-Asp-His-DPhe-Arg-Trp-Asn-Ala-Phe-Dpr]-Tyr-NH2 peptide template.
Wilczynski A; Wilson KR; Scott JW; Edison AS; Haskell-Luevano C
J Med Chem; 2005 Apr; 48(8):3060-75. PubMed ID: 15828845
[TBL] [Abstract][Full Text] [Related]
4. Identification of putative agouti-related protein(87-132)-melanocortin-4 receptor interactions by homology molecular modeling and validation using chimeric peptide ligands.
Wilczynski A; Wang XS; Joseph CG; Xiang Z; Bauzo RM; Scott JW; Sorensen NB; Shaw AM; Millard WJ; Richards NG; Haskell-Luevano C
J Med Chem; 2004 Apr; 47(9):2194-207. PubMed ID: 15084118
[TBL] [Abstract][Full Text] [Related]
5. Melanocortin tetrapeptide Ac-His-DPhe-Arg-Trp-NH2 modified at the para position of the benzyl side chain (DPhe): importance for mouse melanocortin-3 receptor agonist versus antagonist activity.
Proneth B; Pogozheva ID; Portillo FP; Mosberg HI; Haskell-Luevano C
J Med Chem; 2008 Sep; 51(18):5585-93. PubMed ID: 18800761
[TBL] [Abstract][Full Text] [Related]
6. Structure-activity relationships of the melanocortin tetrapeptide Ac-His-D-Phe-Arg-Trp-NH2 at the mouse melanocortin receptors. 4. Modifications at the Trp position.
Holder JR; Xiang Z; Bauzo RM; Haskell-Luevano C
J Med Chem; 2002 Dec; 45(26):5736-44. PubMed ID: 12477357
[TBL] [Abstract][Full Text] [Related]
7. De novo design, synthesis, and pharmacology of alpha-melanocyte stimulating hormone analogues derived from somatostatin by a hybrid approach.
Han G; Haskell-Luevano C; Kendall L; Bonner G; Hadley ME; Cone RD; Hruby VJ
J Med Chem; 2004 Mar; 47(6):1514-26. PubMed ID: 14998337
[TBL] [Abstract][Full Text] [Related]
8. Structure-Activity Relationship Studies of a Macrocyclic AGRP-Mimetic Scaffold c[Pro-Arg-Phe-Phe-Asn-Ala-Phe-DPro] Yield Potent and Selective Melanocortin-4 Receptor Antagonists and Melanocortin-5 Receptor Inverse Agonists That Increase Food Intake in Mice.
Fleming KA; Ericson MD; Freeman KT; Adank DN; Lunzer MM; Wilber SL; Haskell-Luevano C
ACS Chem Neurosci; 2018 May; 9(5):1141-1151. PubMed ID: 29363944
[TBL] [Abstract][Full Text] [Related]
9. Chimeric NDP-MSH and MTII melanocortin peptides with agouti-related protein (AGRP) Arg-Phe-Phe amino acids possess agonist melanocortin receptor activity.
Joseph CG; Wilczynski A; Holder JR; Xiang Z; Bauzo RM; Scott JW; Haskell-Luevano C
Peptides; 2003 Dec; 24(12):1899-908. PubMed ID: 15127941
[TBL] [Abstract][Full Text] [Related]
10. Structure-activity relationships of the melanocortin tetrapeptide Ac-His-DPhe-Arg-Trp-NH(2) at the mouse melanocortin receptors. 1. Modifications at the His position.
Holder JR; Bauzo RM; Xiang Z; Haskell-Luevano C
J Med Chem; 2002 Jun; 45(13):2801-10. PubMed ID: 12061882
[TBL] [Abstract][Full Text] [Related]
11. Multiresidue Tetrapeptide Substitutions Yield a 140-fold Selective Melanocortin-3 over Melanocortin-4 Receptor Agonist.
Ericson MD; Shaikh R; Larson CM; Freeman KT; Haskell-Luevano C
ACS Med Chem Lett; 2021 Jan; 12(1):115-120. PubMed ID: 33488972
[TBL] [Abstract][Full Text] [Related]
12. Discovery of a Pan-Melanocortin Receptor Antagonist [Ac-DPhe(pI)-Arg-Nal(2')-Orn-NH
Ericson MD; Tran LT; Mathre SS; Freeman KT; Holdaway K; John K; Lunzer MM; Bouchard JL; Haskell-Luevano C
J Med Chem; 2023 Jun; 66(12):8103-8117. PubMed ID: 37307241
[TBL] [Abstract][Full Text] [Related]
13. Synthesis and Pharmacology of α/β(3)-Peptides Based on the Melanocortin Agonist Ac-His-dPhe-Arg-Trp-NH2 Sequence.
Singh A; Tala SR; Flores V; Freeman K; Haskell-Luevano C
ACS Med Chem Lett; 2015 May; 6(5):568-72. PubMed ID: 26005535
[TBL] [Abstract][Full Text] [Related]
14. γ₂-Melanocyte stimulation hormone (γ₂-MSH) truncation studies results in the cautionary note that γ₂-MSH is not selective for the mouse MC3R over the mouse MC5R.
Joseph CG; Yao H; Scott JW; Sorensen NB; Marnane RN; Mountjoy KG; Haskell-Luevano C
Peptides; 2010 Dec; 31(12):2304-13. PubMed ID: 20833220
[TBL] [Abstract][Full Text] [Related]
15. Discovery of Melanocortin Ligands via a Double Simultaneous Substitution Strategy Based on the Ac-His-dPhe-Arg-Trp-NH
Todorovic A; Lensing CJ; Holder JR; Scott JW; Sorensen NB; Haskell-Luevano C
ACS Chem Neurosci; 2018 Nov; 9(11):2753-2766. PubMed ID: 29783840
[TBL] [Abstract][Full Text] [Related]
16. Structure⁻Activity Relationships of the Tetrapeptide Ac-His-Arg-(
Schlasner KN; Ericson MD; Doering SR; Freeman KT; Weinrich M; Haskell-Luevano C
Molecules; 2019 Apr; 24(8):. PubMed ID: 31013889
[TBL] [Abstract][Full Text] [Related]
17. Synergistic Multiresidue Substitutions of a Macrocyclic c[Pro-Arg-Phe-Phe-Asn-Ala-Phe-dPro] Agouti-Related Protein (AGRP) Scaffold Yield Potent and >600-Fold MC4R versus MC3R Selective Melanocortin Receptor Antagonists.
Fleming KA; Freeman KT; Ericson MD; Haskell-Luevano C
J Med Chem; 2018 Sep; 61(17):7729-7740. PubMed ID: 30035543
[TBL] [Abstract][Full Text] [Related]
18. Structure-activity relationships of peptides incorporating a bioactive reverse-turn heterocycle at the melanocortin receptors: identification of a 5800-fold mouse melanocortin-3 receptor (mMC3R) selective antagonist/partial agonist versus the mouse melanocortin-4 receptor (mMC4R).
Singh A; Dirain M; Witek R; Rocca JR; Edison AS; Haskell-Luevano C
J Med Chem; 2013 Apr; 56(7):2747-63. PubMed ID: 23432160
[TBL] [Abstract][Full Text] [Related]
19. Stereochemical studies of the monocyclic agouti-related protein (103-122) Arg-Phe-Phe residues: conversion of a melanocortin-4 receptor antagonist into an agonist and results in the discovery of a potent and selective melanocortin-1 agonist.
Joseph CG; Wang XS; Scott JW; Bauzo RM; Xiang Z; Richards NG; Haskell-Luevano C
J Med Chem; 2004 Dec; 47(27):6702-10. PubMed ID: 15615519
[TBL] [Abstract][Full Text] [Related]
20. Comparative Functional Alanine Positional Scanning of the α-Melanocyte Stimulating Hormone and NDP-Melanocyte Stimulating Hormone Demonstrates Differential Structure-Activity Relationships at the Mouse Melanocortin Receptors.
Todorovic A; Ericson MD; Palusak RD; Sorensen NB; Wood MS; Xiang Z; Haskell-Luevano C
ACS Chem Neurosci; 2016 Jul; 7(7):984-94. PubMed ID: 27135265
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
